NCT01893827View on ClinicalTrials.gov

Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care

PHASE4CompletedINTERVENTIONAL
Enrollment

237

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 3, 2018

Study Completion Date

October 3, 2018

Conditions
Alcohol Dependence
Interventions
DRUG

XR-NTX (Extended-Release Naltrexone)

380mg (4cc) XR-NTX administered by IM injection 1x/month for 6 months.

DRUG

Oral Naltrexone (O-NTX)

50mg pill form of naltrexone taken 1x/day for 6 months.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT01893827 - Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care | Biotech Hunter | Biotech Hunter